 | • レポートコード：D0GIR-02494 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血管炎治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。血管炎治療の種類別市場規模（大型、中型、小型）、用途別市場規模（病院、診療所、診断センター、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbvie、Biogen、Anthera Pharmaceuticals、Ablynx、Baxter、Amgen、Celgene、Astrazeneca、Aspen Pharmacare Holdings、Bristol-Myers Squibb、Eli Lilly、Gilead、Celltrion、Human Genome Sciences、F. Hoffmann-La Roche、Eisai、Chemocentryx、Glaxosmithkline、Genentech、Chugai Pharma Usa ・地域別グローバル市場分析 2015年-2020年 ・血管炎治療の北米市場（アメリカ、カナダ、メキシコ） ・血管炎治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・血管炎治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・血管炎治療の南米市場（ブラジル、アルゼンチン） ・血管炎治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：大型、中型、小型 ・用途別分析：病院、診療所、診断センター、研究所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Vasculitis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Vasculitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Vasculitis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vasculitis Treatment market has been segmented into:
Large Vessels
Medium Vessels
Small Vessels
By Application, Vasculitis Treatment has been segmented into:
Hospitals And Clinics
Diagnosis Center
Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vasculitis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Vasculitis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vasculitis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Vasculitis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Vasculitis Treatment Market Share Analysis
Vasculitis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vasculitis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vasculitis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Vasculitis Treatment are:
Abbvie
Biogen
Anthera Pharmaceuticals
Ablynx
Baxter
Amgen
Celgene
Astrazeneca
Aspen Pharmacare Holdings
Bristol-Myers Squibb
Eli Lilly
Gilead
Celltrion
Human Genome Sciences
F. Hoffmann-La Roche
Eisai
Chemocentryx
Glaxosmithkline
Genentech
Chugai Pharma Usa
Table of Contents
1 Vasculitis Treatment Market Overview
1.1 Product Overview and Scope of Vasculitis Treatment
1.2 Classification of Vasculitis Treatment by Type
1.2.1 Global Vasculitis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Vasculitis Treatment Revenue Market Share by Type in 2019
1.2.3 Large Vessels
1.2.4 Medium Vessels
1.2.5 Small Vessels
1.3 Global Vasculitis Treatment Market by Application
1.3.1 Overview: Global Vasculitis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals And Clinics
1.3.3 Diagnosis Center
1.3.4 Research Institutes
1.3.5 Others
1.4 Global Vasculitis Treatment Market by Regions
1.4.1 Global Vasculitis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Vasculitis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Vasculitis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Vasculitis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Vasculitis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Vasculitis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Vasculitis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbvie
2.1.1 Abbvie Details
2.1.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbvie SWOT Analysis
2.1.4 Abbvie Product and Services
2.1.5 Abbvie Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen SWOT Analysis
2.2.4 Biogen Product and Services
2.2.5 Biogen Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Anthera Pharmaceuticals
2.3.1 Anthera Pharmaceuticals Details
2.3.2 Anthera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Anthera Pharmaceuticals SWOT Analysis
2.3.4 Anthera Pharmaceuticals Product and Services
2.3.5 Anthera Pharmaceuticals Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ablynx
2.4.1 Ablynx Details
2.4.2 Ablynx Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ablynx SWOT Analysis
2.4.4 Ablynx Product and Services
2.4.5 Ablynx Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Baxter SWOT Analysis
2.5.4 Baxter Product and Services
2.5.5 Baxter Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celgene
2.7.1 Celgene Details
2.7.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celgene SWOT Analysis
2.7.4 Celgene Product and Services
2.7.5 Celgene Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Astrazeneca
2.8.1 Astrazeneca Details
2.8.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Astrazeneca SWOT Analysis
2.8.4 Astrazeneca Product and Services
2.8.5 Astrazeneca Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Aspen Pharmacare Holdings
2.9.1 Aspen Pharmacare Holdings Details
2.9.2 Aspen Pharmacare Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Aspen Pharmacare Holdings SWOT Analysis
2.9.4 Aspen Pharmacare Holdings Product and Services
2.9.5 Aspen Pharmacare Holdings Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb SWOT Analysis
2.10.4 Bristol-Myers Squibb Product and Services
2.10.5 Bristol-Myers Squibb Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Eli Lilly SWOT Analysis
2.11.4 Eli Lilly Product and Services
2.11.5 Eli Lilly Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Gilead
2.12.1 Gilead Details
2.12.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Gilead SWOT Analysis
2.12.4 Gilead Product and Services
2.12.5 Gilead Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Celltrion
2.13.1 Celltrion Details
2.13.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Celltrion SWOT Analysis
2.13.4 Celltrion Product and Services
2.13.5 Celltrion Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Human Genome Sciences
2.14.1 Human Genome Sciences Details
2.14.2 Human Genome Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Human Genome Sciences SWOT Analysis
2.14.4 Human Genome Sciences Product and Services
2.14.5 Human Genome Sciences Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 F. Hoffmann-La Roche
2.15.1 F. Hoffmann-La Roche Details
2.15.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 F. Hoffmann-La Roche SWOT Analysis
2.15.4 F. Hoffmann-La Roche Product and Services
2.15.5 F. Hoffmann-La Roche Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Eisai SWOT Analysis
2.16.4 Eisai Product and Services
2.16.5 Eisai Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Chemocentryx
2.17.1 Chemocentryx Details
2.17.2 Chemocentryx Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Chemocentryx SWOT Analysis
2.17.4 Chemocentryx Product and Services
2.17.5 Chemocentryx Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Glaxosmithkline
2.18.1 Glaxosmithkline Details
2.18.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Glaxosmithkline SWOT Analysis
2.18.4 Glaxosmithkline Product and Services
2.18.3 Glaxosmithkline Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Genentech
2.19.1 Genentech Details
2.19.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Genentech SWOT Analysis
2.19.4 Genentech Product and Services
2.19.5 Genentech Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 Chugai Pharma Usa
2.20.1 Chugai Pharma Usa Details
2.20.2 Chugai Pharma Usa Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Chugai Pharma Usa SWOT Analysis
2.20.4 Chugai Pharma Usa Product and Services
2.20.5 Chugai Pharma Usa Vasculitis Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Vasculitis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Vasculitis Treatment Players Market Share
3.2.2 Top 10 Vasculitis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Vasculitis Treatment Revenue and Market Share by Regions
4.2 North America Vasculitis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Vasculitis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Vasculitis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Vasculitis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Vasculitis Treatment Revenue and Growth Rate (2015-2020)
5 North America Vasculitis Treatment Revenue by Countries
5.1 North America Vasculitis Treatment Revenue by Countries (2015-2020)
5.2 USA Vasculitis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Vasculitis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Vasculitis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Vasculitis Treatment Revenue by Countries
6.1 Europe Vasculitis Treatment Revenue by Countries (2015-2020)
6.2 Germany Vasculitis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Vasculitis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Vasculitis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Vasculitis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Vasculitis Treatment Revenue by Countries
7.1 Asia-Pacific Vasculitis Treatment Revenue by Countries (2015-2020)
7.2 China Vasculitis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Vasculitis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Vasculitis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Vasculitis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
8 South America Vasculitis Treatment Revenue by Countries
8.1 South America Vasculitis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Vasculitis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Vasculitis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Vasculitis Treatment by Countries
9.1 Middle East & Africa Vasculitis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Vasculitis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Vasculitis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Vasculitis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Vasculitis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Vasculitis Treatment Market Forecast by Type (2019-2024)
10.3 Large Vessels Revenue Growth Rate (2015-2025)
10.4 Medium Vessels Revenue Growth Rate (2015-2025)
10.5 Small Vessels Revenue Growth Rate (2015-2025)
11 Global Vasculitis Treatment Market Segment by Application
11.1 Global Vasculitis Treatment Revenue Market Share by Application (2015-2020)
11.2 Vasculitis Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals And Clinics Revenue Growth (2015-2020)
11.4 Diagnosis Center Revenue Growth (2015-2020)
11.5 Research Institutes Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Vasculitis Treatment Market Size Forecast (2021-2025)
12.1 Global Vasculitis Treatment Market Size Forecast (2021-2025)
12.2 Global Vasculitis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Vasculitis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Vasculitis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Vasculitis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Vasculitis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Vasculitis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Vasculitis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vasculitis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vasculitis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Vasculitis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbvie Corporate Information, Location and Competitors
Table 6. Abbvie Vasculitis Treatment Major Business
Table 7. Abbvie Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbvie SWOT Analysis
Table 9. Abbvie Vasculitis Treatment Product and Solutions
Table 10. Abbvie Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biogen Corporate Information, Location and Competitors
Table 12. Biogen Vasculitis Treatment Major Business
Table 13. Biogen Vasculitis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Biogen SWOT Analysis
Table 15. Biogen Vasculitis Treatment Product and Solutions
Table 16. Biogen Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Anthera Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Anthera Pharmaceuticals Vasculitis Treatment Major Business
Table 19. Anthera Pharmaceuticals Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Anthera Pharmaceuticals SWOT Analysis
Table 21. Anthera Pharmaceuticals Vasculitis Treatment Product and Solutions
Table 22. Anthera Pharmaceuticals Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Ablynx Corporate Information, Location and Competitors
Table 24. Ablynx Vasculitis Treatment Major Business
Table 25. Ablynx Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Ablynx SWOT Analysis
Table 27. Ablynx Vasculitis Treatment Product and Solutions
Table 28. Ablynx Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Baxter Corporate Information, Location and Competitors
Table 30. Baxter Vasculitis Treatment Major Business
Table 31. Baxter Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Baxter SWOT Analysis
Table 33. Baxter Vasculitis Treatment Product and Solutions
Table 34. Baxter Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Amgen Corporate Information, Location and Competitors
Table 36. Amgen Vasculitis Treatment Major Business
Table 37. Amgen Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Amgen SWOT Analysis
Table 39. Amgen Vasculitis Treatment Product and Solutions
Table 40. Amgen Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Celgene Corporate Information, Location and Competitors
Table 42. Celgene Vasculitis Treatment Major Business
Table 43. Celgene Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Celgene SWOT Analysis
Table 45. Celgene Vasculitis Treatment Product and Solutions
Table 46. Celgene Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Astrazeneca Corporate Information, Location and Competitors
Table 48. Astrazeneca Vasculitis Treatment Major Business
Table 49. Astrazeneca Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Astrazeneca SWOT Analysis
Table 51. Astrazeneca Vasculitis Treatment Product and Solutions
Table 52. Astrazeneca Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Aspen Pharmacare Holdings Corporate Information, Location and Competitors
Table 54. Aspen Pharmacare Holdings Vasculitis Treatment Major Business
Table 55. Aspen Pharmacare Holdings Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Aspen Pharmacare Holdings SWOT Analysis
Table 57. Aspen Pharmacare Holdings Vasculitis Treatment Product and Solutions
Table 58. Aspen Pharmacare Holdings Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Vasculitis Treatment Major Business
Table 61. Bristol-Myers Squibb Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb SWOT Analysis
Table 63. Bristol-Myers Squibb Vasculitis Treatment Product and Solutions
Table 64. Bristol-Myers Squibb Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Eli Lilly Corporate Information, Location and Competitors
Table 66. Eli Lilly Vasculitis Treatment Major Business
Table 67. Eli Lilly Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Eli Lilly SWOT Analysis
Table 69. Eli Lilly Vasculitis Treatment Product and Solutions
Table 70. Eli Lilly Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Gilead Corporate Information, Location and Competitors
Table 72. Gilead Vasculitis Treatment Major Business
Table 73. Gilead Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Gilead SWOT Analysis
Table 75. Gilead Vasculitis Treatment Product and Solutions
Table 76. Gilead Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Celltrion Corporate Information, Location and Competitors
Table 78. Celltrion Vasculitis Treatment Major Business
Table 79. Celltrion Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Celltrion SWOT Analysis
Table 81. Celltrion Vasculitis Treatment Product and Solutions
Table 82. Celltrion Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Human Genome Sciences Corporate Information, Location and Competitors
Table 84. Human Genome Sciences Vasculitis Treatment Major Business
Table 85. Human Genome Sciences Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Human Genome Sciences SWOT Analysis
Table 87. Human Genome Sciences Vasculitis Treatment Product and Solutions
Table 88. Human Genome Sciences Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 90. F. Hoffmann-La Roche Vasculitis Treatment Major Business
Table 91. F. Hoffmann-La Roche Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 92. F. Hoffmann-La Roche SWOT Analysis
Table 93. F. Hoffmann-La Roche Vasculitis Treatment Product and Solutions
Table 94. F. Hoffmann-La Roche Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Eisai Corporate Information, Location and Competitors
Table 96. Eisai Vasculitis Treatment Major Business
Table 97. Eisai Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Eisai SWOT Analysis
Table 99. Eisai Vasculitis Treatment Product and Solutions
Table 100. Eisai Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Chemocentryx Corporate Information, Location and Competitors
Table 102. Chemocentryx Vasculitis Treatment Major Business
Table 103. Chemocentryx Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Chemocentryx SWOT Analysis
Table 105. Chemocentryx Vasculitis Treatment Product and Solutions
Table 106. Chemocentryx Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Glaxosmithkline Vasculitis Treatment Type and Application
Table 108. Glaxosmithkline Vasculitis Treatment Major Business
Table 109. Glaxosmithkline Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 110. Glaxosmithkline SWOT Analysis
Table 111. Glaxosmithkline Vasculitis Treatment Product and Solutions
Table 112. Glaxosmithkline Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Genentech Corporate Information, Location and Competitors
Table 114. Genentech Vasculitis Treatment Major Business
Table 115. Genentech Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Genentech SWOT Analysis
Table 117. Genentech Vasculitis Treatment Product and Solutions
Table 118. Genentech Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Chugai Pharma Usa Corporate Information, Location and Competitors
Table 120. Chugai Pharma Usa Vasculitis Treatment Major Business
Table 121. Chugai Pharma Usa Vasculitis Treatment Total Revenue (USD Million) (2017-2018)
Table 122. Chugai Pharma Usa SWOT Analysis
Table 123. Chugai Pharma Usa Vasculitis Treatment Product and Solutions
Table 124. Chugai Pharma Usa Vasculitis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Vasculitis Treatment Revenue (Million USD) by Players (2015-2020)
Table 126. Global Vasculitis Treatment Revenue Share by Players (2015-2020)
Table 127. Global Vasculitis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Vasculitis Treatment Revenue Market Share by Regions (2015-2020)
Table 129. North America Vasculitis Treatment Revenue by Countries (2015-2020)
Table 130. North America Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Table 131. Europe Vasculitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Vasculitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Vasculitis Treatment Revenue by Countries (2015-2020)
Table 134. South America Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Vasculitis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Table 137. Global Vasculitis Treatment Revenue (Million USD) by Type (2015-2020)
Table 138. Global Vasculitis Treatment Revenue Share by Type (2015-2020)
Table 139. Global Vasculitis Treatment Revenue Forecast by Type (2021-2025)
Table 140. Global Vasculitis Treatment Revenue by Application (2015-2020)
Table 141. Global Vasculitis Treatment Revenue Share by Application (2015-2020)
Table 142. Global Vasculitis Treatment Revenue Forecast by Application (2021-2025)
Table 143. Global Vasculitis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Vasculitis Treatment Picture
Figure 2. Global Vasculitis Treatment Revenue Market Share by Type in 2019
Figure 3. Large Vessels Picture
Figure 4. Medium Vessels Picture
Figure 5. Small Vessels Picture
Figure 6. Vasculitis Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals And Clinics Picture
Figure 8. Diagnosis Center Picture
Figure 9. Research Institutes Picture
Figure 10. Others Picture
Figure 11. Global Vasculitis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Vasculitis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Vasculitis Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Vasculitis Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Vasculitis Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Vasculitis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Vasculitis Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Vasculitis Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Vasculitis Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Vasculitis Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Vasculitis Treatment Revenue Market Share by Countries in 2019
Figure 44. China Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Vasculitis Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Vasculitis Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Vasculitis Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Vasculitis Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Vasculitis Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Vasculitis Treatment Revenue Share by Type in 2019
Figure 61. Global Vasculitis Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Large Vessels Revenue Growth Rate (2015-2020)
Figure 63. Global Medium Vessels Revenue Growth Rate (2015-2020)
Figure 64. Global Small Vessels Revenue Growth Rate (2015-2020)
Figure 65. Global Vasculitis Treatment Revenue Share by Application (2015-2020)
Figure 66. Global Vasculitis Treatment Revenue Share by Application in 2019
Figure 67. Global Vasculitis Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals And Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Diagnosis Center Revenue Growth Rate (2015-2020)
Figure 70. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Vasculitis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Vasculitis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Vasculitis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Vasculitis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Vasculitis Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Vasculitis Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Vasculitis Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Vasculitis Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
交流電場腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alternating Electric Field Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Al…- ジフテリア治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Diphtheria Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.7% in the forecast period of 2020 to 2025 and will expected to reach USD 4071.9 million by 2025, from USD 3801 million in 2019. The Diphtheria Treatm…
- 圧縮空気処理装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Compressed Air Treatment Equipment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 7414.1 million by 2025, from USD 6387 million in 2019. The Com…
- 眼瞼炎治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Blepharitis Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 血漿プロテアーゼC1阻害剤治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Plasma Protease C1-inhibitor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma…